ClearPoint Neuro, Inc.
CLPT
$10.64
$0.141.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.68% | 23.22% | 31.04% | 36.34% | 29.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.68% | 23.22% | 31.04% | 36.34% | 29.33% |
| Cost of Revenue | 17.98% | 11.43% | 18.63% | 28.91% | 35.29% |
| Gross Profit | 20.82% | 32.08% | 40.46% | 41.69% | 25.62% |
| SG&A Expenses | 18.54% | 14.93% | 8.60% | 9.86% | 10.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.60% | 14.41% | 10.14% | 10.60% | 8.88% |
| Operating Income | -21.98% | -3.40% | 12.16% | 15.27% | 12.15% |
| Income Before Tax | -23.55% | -0.73% | 14.51% | 17.10% | 13.83% |
| Income Tax Expenses | 43.33% | 120.00% | -- | -- | -- |
| Earnings from Continuing Operations | -23.58% | -0.81% | 14.37% | 16.97% | 13.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.58% | -0.81% | 14.37% | 16.97% | 13.69% |
| EBIT | -21.98% | -3.40% | 12.16% | 15.27% | 12.15% |
| EBITDA | -21.95% | -3.03% | 14.13% | 17.71% | 14.64% |
| EPS Basic | -13.21% | 9.51% | 22.16% | 22.23% | 16.75% |
| Normalized Basic EPS | -13.19% | 9.56% | 22.28% | 22.36% | 16.88% |
| EPS Diluted | -13.21% | 9.51% | 22.16% | 22.23% | 16.75% |
| Normalized Diluted EPS | -13.19% | 9.56% | 22.28% | 22.36% | 16.88% |
| Average Basic Shares Outstanding | 8.79% | 11.16% | 9.84% | 6.90% | 4.03% |
| Average Diluted Shares Outstanding | 8.79% | 11.16% | 9.84% | 6.90% | 4.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |